Masimo Corp. ((MASI)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
FDA gives nation’s only approval for pulse oximetry monitoring to Masimo’s watch Masimo Corp. (Nasdaq: MASI) is about to get a special gift, the day after Christmas. That’s when the U.S. government is ...
Masimo’s revolutionary SET® pulse oximetry has been shown in more than 100 independent and objective studies to outperform other pulse oximetry technologies – even before the revisions that achieved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback